Adjunctive Treatment of Major Depressive Disorder (MDD)
1 clinical trials · Condition
◉ Watch Adjunctive Treatment of Major Depressive Disorder (MDD)
| Record | Firm | Date |
|---|---|---|
| A Study of CLE-100 (Oral Esketamine) as an Adjunctive Treatment to Standard Antidepressants for Major Depressive Disorder (NCT06340958) | Clexio Biosciences Ltd. | 2024-03-18 |
Track Adjunctive Treatment of Major Depressive Disorder (MDD) automatically
Every clearance here is in the API, with alerts when new ones post.